iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd Option Chain

Add as a Preferred Source on Google
2,162.6
(4.79%)
Feb 3, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
4500%₹265.6 0%1,800₹4 -42.44%17,3251440%
--1,860--
2250%₹239.6 0%1,880₹9.6 0%9000%
--1,900₹5.2 -67.8%27,900138.46%
4500%₹201.65 0%1,920₹8.45 -55.52%36,900925%
9000%₹183.65 0%1,940₹28.45 0%2,7000%
2250%₹155 0%1,960₹10.5 -59.61%6,525107.14%
2250%₹139 0%1,980₹20 0%2,9250%
4,5000%₹184.4 69.48%2,000₹17.5 -54.12%1,10,47558.38%
1,1250%₹112.65 0%2,020₹24.55 -45.62%54,675305%
2250%₹126.2 0%2,040₹24.15 -55.19%28,125331.03%
1,800-63.63%₹121.4 59.94%2,060₹34.5 -44.08%43,875134.93%
4,950-4.34%₹112.2 69.1%2,080₹36.55 -50.27%13,27515.68%
47,475-24.10%₹103 74.87%2,100₹48.8 -37.31%1,35,225113.12%
17,550-4.87%₹94.25 98.42%2,120₹104 0%13,9500%
62,5500.36%₹79.1 93.39%2,140₹68 -39.95%36,00011.11%
22,500100%₹69.25 96.73%2,160₹76 -15.83%13,500300%
28,575182.22%₹59.05 95.52%2,180₹109.45 0%6750%
1,14,0751.60%₹55 104.08%2,200₹87 -45.21%18,0005.26%
5,1752200%₹46 43.75%2,220₹105.45 -19.93%0-100%
40,95068.51%₹42 128.26%2,240₹102 -34.8%2,4750%
21,600540%₹39.55 134.02%2,260₹125.4 -29.68%900100%
6750%₹31 0%2,280--
1,37,250117.08%₹24 129.66%2,300₹255 0%12,1500%
64,350160%₹15.15 47.8%2,320--
27,000445.45%₹19.45 20.06%2,340₹242.95 0%2,4750%
21,3759400%₹18 -21.9%2,360₹245 0%2250%
78,750224.07%₹13.35 169.69%2,400₹289.1 0%6,3000%
9000%₹6.3 0%2,420₹325.25 0%9000%
2,700500%₹8.85 59.45%2,440₹305 0%4500%
6750%₹4.8 0%2,460₹315 0%2,4750%
2,69,1007375%₹7.85 93.82%2,500₹355.4 -10.7%4,9504.76%
8,7751200%₹5.8 56.75%2,520₹419.4 0%6750%
--2,600₹485 0%4500%
--2,640₹510 0%2250%

Mankind Pharma: Related NEWS

Mankind Pharma Q1 Updates: Net profit down ~18%

The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.

1 Aug 2025|01:41 PM
Read More
Top Stocks for Today - 01st August 2025

Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.

1 Aug 2025|08:58 AM
Read More
Mankind Pharma posts mixed performance in Q4; stock slips ~4%

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

22 May 2025|12:15 PM
Read More
Top Stocks for Today - 22nd May 2025

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

22 May 2025|06:38 AM
Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand

The cumulative demand, including interest charges, is ₹183.11 crore.

30 Mar 2025|04:34 PM
Read More
Mankind Pharma Merges Three Subsidiaries

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

30 Mar 2025|01:33 PM
Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

28 Feb 2025|11:13 PM
Read More
Top Stocks for Today - 24th January 2025

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

24 Jan 2025|07:50 AM
Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

23 Jan 2025|11:57 PM
Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

8 Jan 2025|04:01 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.